External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline
Practical Radiation Oncology · 2024-09 · 14 (5) · 377-397
DOI: 10.1016/j.prro.2024.04.018 ↗Kurz gefasst
Leitlinie in der Zeitschrift Practical Radiation Oncology, 2024-09. Verfasst von Sara Alcorn und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota. Electronic address: alcor049@umn.edu. Hauptthemen laut MEDLINE: Palliative Care, Bone Neoplasms. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: Agency for Healthcare Research and Quality, Patient-Centered Outcomes Research Institute, ASTRO.
Abstract (Originalsprache)
PURPOSE: This guideline provides evidence-based recommendations for palliative external beam radiation therapy (RT) in symptomatic bone metastases. METHODS: The ASTRO convened a task force to address 5 key questions regarding palliative RT in symptomatic bone metastases. Based on a systematic review by the Agency for Health Research and Quality, recommendations using predefined consensus-building methodology were established; evidence quality and recommendation strength were also assessed. RESULTS: For palliative RT for symptomatic bone metastases, RT is recommended for managing pain from bone metastases and spine metastases with or without spinal cord or cauda equina compression. Regarding other modalities with RT, for patients with spine metastases causing spinal cord or cauda equina compression, surgery and postoperative RT are conditionally recommended over RT alone. Furthermore, dexamethasone is recommended for spine metastases with spinal cord or cauda equina compression. Patients with nonspine bone metastases requiring surgery are recommended postoperative RT. Symptomatic bone metastases treated with conventional RT are recommended 800 cGy in 1 fraction (800 cGy/1 fx), 2000 cGy/5 fx, 2400 cGy/6 fx, or 3000 cGy/10 fx. Spinal cord or cauda equina compression in patients who are ineligible for surgery and receiving conventional RT are recommended 800 cGy/1 fx, 1600 cGy/2 fx, 2000 cGy/5 fx, or 3000 cGy/10 fx. Symptomatic bone metastases in selected patients with good performance status without surgery or neurologic symptoms/signs are conditionally recommended stereotactic body RT over conventional palliative RT. Spine bone metastases reirradiated with conventional RT are recommended 800 cGy/1 fx, 2000 cGy/5 fx, 2400 cGy/6 fx, or 2000 cGy/8 fx; nonspine bone metastases reirradiated with conventional RT are recommended 800 cGy/1 fx, 2000 cGy/5 fx, or 2400 cGy/6 fx. Determination of an optimal RT approach/regimen requires whole person assessment, including prognosis, previous RT dose if applicable, risks to normal tissues, quality of life, cost implications, and patient goals and values. Relatedly, for patient-centered optimization of treatment-related toxicities and quality of life, shared decision making is recommended. CONCLUSIONS: Based on published data, the ASTRO task force's recommendations inform best clinical practices on palliative RT for symptomatic bone metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota. Electronic address: alcor049@umn.edu.
- Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
- American Society for Radiation Oncology, Arlington, Virginia.
- Patient Representative, Baltimore, Maryland.
- Division of Radiation Oncology, Ottawa Hospital and University of Ottawa, Ottawa, Ontario, Canada.
- Department of Radiation Oncology, Ohio State University, Columbus, Ohio.
Förderung
- Agency for Healthcare Research and Quality
- Patient-Centered Outcomes Research Institute
- ASTRO
Zitieren
APA
Alcorn, S., Cortés, Á. A., Bradfield, L., Brennan, M., Dennis, K., Diaz, D. A., Doung, Y. C., Elmore, S., Hertan, L., Johnstone, C., Jones, J., Larrier, N., Lo, S. S., Nguyen, Q. N., Tseng, Y. D., Yerramilli, D., Zaky, S., & Balboni, T. (2024). External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology, 14(5), 377-397. https://doi.org/10.1016/j.prro.2024.04.018
Vancouver
Alcorn S, Cortés ÁA, Bradfield L, Brennan M, Dennis K, Diaz DA, et al. External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology. 2024;14(5):377-397. doi:10.1016/j.prro.2024.04.018
BibTeX
@article{Alcorn2024,
author = {Alcorn, Sara and Cortés, Ángel Artal and Bradfield, Lisa and Brennan, Margaret and Dennis, Kristopher and Diaz, Dayssy A and Doung, Yee-Cheen and Elmore, Shekinah and Hertan, Lauren and Johnstone, Candice and Jones, Joshua and Larrier, Nicole and Lo, Simon S and Nguyen, Quynh-Nhu and Tseng, Yolanda D and Yerramilli, Divya and Zaky, Sandra and Balboni, Tracy},
title = {External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline},
journal = {Practical Radiation Oncology},
year = {2024},
volume = {14},
number = {5},
pages = {377--397},
doi = {10.1016/j.prro.2024.04.018}
}
EUVIMED